$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%
Morning BriefingTuesday, Jun 9, 2026
Buy Zone5 picks: ONDS, SMCI, NVTS…
Exit Alerts0 warnings issued
Fear & GreedGREED67
SPY ETF+0.78% (Pre-Market)
Livesync 0s ago
Callers
Single-call
Leaderboard #406

@BPharmCatalyst

Was 3 days early on $SNSE. A single call this early is luck or genius — we track until we know which.

View @BPharmCatalyst on X
Score
0.112
0.5+ = strong
Best lead
3d
on $SNSE
Winners
1
single call
Pre-run tweets
1
substantive only

Calls breakdown

$SNSECalled 3 days before runClosed
first mention: Apr 29, 2024
“$SNSE Phase 1/2 trial testing SNS-101 + Libtayo for solid tumors. Early safety data in, full results at ASCO 6/1. Check our weekly #watchlist for more upcoming catalyst biopharmcatalyst.com/news/20…”
View tweet
6 other callers also flagged $SNSE pre-run:
PR
@ProfitGrand
LT
@LTbioinvestor
BI
@BioValues
MA
@MarcJacksonLA
OZ
@OzmosiHealth
MO
@monaco_biotech